B. Alcazar Navarrete (Cájar, Spain), M. Brusse-Keizer (Enschede, Netherlands)
Sputum rheology in stable and exacerbated chronic obstructive pulmonary disease A. Abdi (Basel, Switzerland), D. Schumann (Basel, Switzerland), L. Franchetti (Basel, Switzerland), W. Chen (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Variability of fractional exhaled nitric oxide may predict acute exacerbations in COPD E. Papakonstantinou (Basel, Switzerland), D. Schumann (Basel, Switzerland), K. Kostikas (Ioannina, Greece), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Freiburg, Germany)
| |
Symmetric Projection Attractor Reconstruction: Analysis of waveform morphology predicts COPD exacerbations M. Serna Pascual (London, United Kingdom), R. D'Cruz (London, United Kingdom), Y. Huang (Surrey, United Kingdom), P. Aston (Surrey, United Kingdom), C. Jolley (London, United Kingdom), G. Rafferty (London, United Kingdom), J. Steier (London, United Kingdom), M. Nandi (London, United Kingdom)
| |
Clinical characteristics of eosinophilic and noneosinophilic exacerbations of COPD: relationship with sputum eosinophils and FENO B. Antus (Budapest, Hungary), C. Paska (Budapest, Hungary), I. Barta (Budapest, Hungary)
| |
Respiratory reactance is related to future COPD exacerbations K. Lingman (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Clinical consequences of health measures and lock down for covid-19 in exacerbations in patients with chronic obstructive pulmonary disease (COPD) C. Manzano (Lleida, Spain), L. Alcarraz (Lleida, Spain), A. Moncusí (Lleida, Spain), S. Santisteve (Lleida, Spain), J. Gonzalez (Lleida, Spain), F. Barbé (Lleida, Spain)
| |
SYSTEMIC PROTEOMIC PROFILES OF COPD PATIENTS AT CLINICAL STABILITY AND EXACERBATION C. Enriquez-Rodríguez (Barcelona, Spain), C. Casadevall (Barcelona, Spain), S. Pascual-Guardia (Barcelona, Spain), R. Faner (Barcelona, Spain), G. Peces-Barba (Madrid, Spain), J. López-Campos (Sevilla, Spain), E. Monsó (Barcelona, Spain), A. Agustí (Barcelona, Spain), J. Gea Guiral (Barcelona, Spain)
| |
Relationship between the microbiome and the GOLD Stage during exacerbations R. Lopez-Aladid (Barcelona, Spain), L. Fernandez Barat (Barcelona, Spain), L. Bueno-Freire (Barcelona, Spain), A. Ceccato (Barcelona, Spain), A. Huerta (Barcelona, Spain), N. Soler (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Heart Rate Recovery After Cardiopulmonary exercise test Predicts Acute Exacerbation in COPD s. nie (Beijing, China), A. Yang (Beijing, China), W. Yuan (Beijing, China), B. Xu (Beijing, China), N. Jia (Beijing, China), H. Wang (Beijing, China)
| |
Modifiable factors associated with acute exacerbations in patients with chronic obstructive pulmonary disease S. Begum (Trivandrum, India), R. Nair (Trivandrum, India), K. R (Trivandrum, India), A. K (Trivandrum, India)
| |
COVID-19 incidence and hospitalization in routine clinical practice among COPD patients in England in 2020 K. Rothnie (London, United Kingdom), T. Tritton (Bollington, United Kingdom), X. Han (Collegeville, United States), T. Holbrook (Bollington, United Kingdom), B. Numbere (London, United Kingdom), A. Ford (Bollington, United Kingdom), L. Massey (Bollington, United Kingdom), Q. Fu (Collegeville, United States), F. Hutchinson (Dublin, Ireland), H. Birch (Brentford, United Kingdom), D. Leather (London, United Kingdom), R. Sharma (London, United Kingdom), C. Compton (London, United Kingdom), A. Ismaila (Collegeville, United States)
| |
Impact of rs16969968 polymorphism (SNPa5) on epithelial differentiation in COPD patients L. SABER CHERIF (REIMS, France), Z. Diabasana (REIMS, France), J. Perotin (REIMS, France), J. Ancel (REIMS, France), P. Gosset (Lille, France), U. Maskos (Paris, France), G. Deslée (Reims, France), V. Dormoy (Reims, France)
| |
COPD and COVID-19: a dangerous association? L. Méndez González (Santa Maria da Feira, Portugal), J. Ferreira (Santa Maria da Feira, Portugal), C. Caneiras (Lisbon, Portugal)
| |
Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio a useful markers to predict the severity of COPD and future acute exacerbation? O. Asma (Sousse, Tunisia), A. Sana (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), K. Ameni (Kairouan, Tunisia), G. Imene (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia)
| |
A visual and innovative representation of the clinical trajectory of patients after an acute exacerbation of COPD. Results of the COHERENT-COPD study G. Siesto López (Madrid, Spain), J. Sánchez-Covisa Hernández (Madrid, Spain), C. Goñi Echeverría (Madrid, Spain), H. Bueno Zamora (Madrid, Spain), J. Bernal Sobrino (Madrid, Spain), M. Juarez Campo (Madrid, Spain), M. Piñeiro Roncal (Madrid, Spain), M. Tejedor Ortiz (Madrid, Spain), C. Álvarez Marínez (Madrid, Spain)
| |
Utility of echocardiographic measurement in assessing pulmonary arterial hypertension (PH) in COPD and correlation with severity and potential risk of acute exacerbation within 30 days O. Asma (Sousse, Tunisia), A. Sana (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), K. Amani (Kairouan, Tunisia), G. Imene (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia)
| |
Mortality according to age, sex, or congestive heart failure after an acute COPD exacerbation. COHERENT-COPD study. M. Piñeiro Roncal (Madrid, Spain), E. Catalinas Muñoz (Madrid, Spain), J. Sánchez-Covisa Hernández (Madrid, Spain), C. Goñi Echevarría (Madrid, Spain), H. Bueno Zamora (Madrid, Spain), J. Bernal Sobrino (Madrid, Spain), M. Juarez Campo (Madrid, Spain), M. Tejedor Ortiz (Madrid, Spain), G. Siesto López (Madrid, Spain), C. Álvarez Martínez (Madrid, Spain)
| |
Applying machine learning to telehealth care data to predict acute COPD exacerbations. P. Jacobson (LINKÖPING, Sweden), M. Santini (STOCKHOLM, Sweden), L. Lind (LINKÖPING, Sweden), H. Persson (LINKÖPING, Sweden)
| |
Blood eosinophil counts during severe exacerbations do not reflect stable state inflammatory phenotype in COPD A. Prasad (North Shields, United Kingdom), C. Echevarria (Newcastle, United Kingdom), J. Steer (North Shields, United Kingdom), S. Bourke (North Shields, United Kingdom)
| |
Hyperhomocysteinemia as the main thrombophilic risk marker in COPD E. Abduganieva (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan)
| |